Brain scan and rTMS study for suicidal thoughts in opioid users
Part of Mental health clinical trials.
This study looks at brain connectivity using an MRI scan and then treats some people with rTMS (a non-surgical brain stimulation). It’s designed for adults who use opioids and currently have active suicidal thoughts, to better understand and help those symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18–60 and able to complete study visits
- For the opioid group: have an opioid use level shown by a WHO screening score of 4+ (opioid section)
- Have depression symptoms on a PHQ-9 questionnaire and active suicidal thoughts on the SBQ-R questionnaire
- You must be able to understand the consent form and sign it (and be willing to do all procedures)
- You must be able to safely have an MRI and rTMS (no certain implanted metal devices; no metal that gets too close to the MRI scanner or rTMS coil)
- If you are female: you must not be pregnant or nursing during the MRI and rTMS treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-invasive brain stimulation treatment (repetitive transcranial magnetic stimulation, or rTMS) in people with major depression who did not respond to antidepressant medicines. It may help some participants improve depression symptoms over time.
This trial tests whether a non-surgical brain stimulation technique (rTMS) can reduce depression symptoms in adults with major depression. You would likely have several study visits that include brain scans (MRI) and treatment sessions to see if symptoms improve.
This study tests a non-invasive brain stimulation technique called TMS to see if it can reduce opioid cravings and help people who are already taking buprenorphine stay in recovery. TMS uses magnetic pulses to stimulate parts of the brain involved in addiction.
This study tests whether a treatment called repetitive transcranial magnetic stimulation (rTMS) can help people with opioid use disorder. It involves a non-invasive procedure that uses magnetic pulses to stimulate certain parts of the brain.
This trial tests if brain stimulation can help people starting buprenorphine for opioid use disorder. It aims to improve treatment outcomes and support recovery.
This Phase 2 study tests whether a brain stimulation treatment called rTMS, plus a controlled stress task, can improve “executive function” (planning, focus, and other higher-level thinking) in people with opioid use disorder. It also checks safety by screening heart health and several medical and mental health factors.
Hear when a new Substance Abuse trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.